Approval · Notice of Compliance 21860 · 2019
ACID REDUCER: Notice of Compliance 21860
Issued February 12, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21860
- Date
- February 12, 2019
- Company
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Labelling update (to match licensor)
- Canadian reference product
- ZANTAC (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACID REDUCER | Not yet assigned | — |
Medicinal ingredients
- RANITIDINE HCL 75 MG per TAB